Viewing Study NCT01139359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-01-27 @ 9:31 PM
Study NCT ID: NCT01139359
Status: WITHDRAWN
Last Update Posted: 2012-07-19
First Post: 2010-06-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma
Sponsor: Alaunos Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Darinaparsin View
None CHOP View
None Frontline View
None PTCL View
None B-cell View